MDxHealth's ConfirmMDx(r) Predicts Prostate Cancer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MDxHealth's ConfirmMDx(r) Predicts Prostate Cancer Aggressiveness

IRVINE, Calif. and HERSTAL, Belgium, May 18, 2015 (GLOBE NEWSWIRE) -- Epigenetic Health Index Helps Urologists with Prognostic Recommendations                                                Data Supporting Expanded Application of ConfirmMDx Presented at the AUA 2015

MDxHealth SA (Euronext: MDXH.BR) revealed data today demonstrating the prognostic value of its ConfirmMDx ® for Prostate Cancer test. The data, presented in two presentations at the American Urology Association (AUA) 2015 Annual Meeting in New Orleans, Louisiana (May 15-21), demonstrate the ConfirmMDx test's ability to identify patients likely to harbor clinically significant prostate cancer from negative biopsy tissue. In histopathology positive biopsies the test showed a better separation between men with aggressive prostate cancer from those men with indolent disease.

Previous diagnostic studies have established the utility of ConfirmMDx as a significant, independent predictor of prostate cancer, with a negative predictive value (NPV) of 90% for all cancers and a NPV of 96% for significant cancers. Now, the prognostic value of ConfirmMDx has also been demonstrated. In the first study on 269 men with a histopathologically negative biopsy results and ConfirmMDx-positive, DNA-methylation levels of the standard 12-core biopsies combined with clinical risk factors were used to develop an Epigenetic Health Index (EHI). The EHI was significantly higher in patients with an aggressive cancer detected upon repeat biopsy. The EHI of patients showed a strong correlation with the National Comprehensive Cancer Network (NCCN) score obtained on a second biopsy taken 3-15 months later. These findings confirm the results from previous studies that ConfirmMDx is able to segregate aggressive from non-aggressive prostate cancer in histopathological negative biopsies.

"Based on the results of this study, we can, with a high degree of confidence, stratify patients based on their ConfirmMDx EHI into low and high risk patients. This additional actionable information from ConfirmMDx will provide urologists with enhanced diagnostic, prognostic and clinical guidance to help manage their patients," stated Prof. Dr. Wim Van Criekinge, CSO of MDxHealth. "This new EHI forms part of an expanded outcome from the ConfirmMDx test that we plan to make available to urologists in the course of 2015."

In the second study, the newly developed EHI was validated in 12-core biopsies from 102 men with either no cancer, insignificant or significant cancer detected upon biopsy. The EHI was significantly higher in those men with high-grade cancer versus those with low-grade cancer. Also in this study, a strong correlation between the EHI and the NCCN risk stratification for prostate cancer was observed. Both of these studies demonstrate that the ConfirmMDx EHI has significant prognostic value and is able to identify men at increased risk for high-grade, aggressive prostate cancer in both histopathology negative and positive biopsies. ConfirmMDx EHI shows a better separation between men with aggressive prostate cancer from those men with indolent disease.

"Currently Gleason scoring and NCCN are the gold standards to assess a patient's risk of harboring aggressive prostate cancer. However, due to the limitations of a standard biopsy procedure the risk is underestimated in up to 30% of men. The EHI might help to better stratify patients and identify more objectively candidates for active surveillance strategies," reported Professor Sandra M. Gaston PhD, Director of Urological Research at New England Baptist Hospital and Director of the Molecular Biomarkers Research Laboratory in the Department of Pathology and Laboratory Medicine at Tufts Medical Center in Boston.

About ConfirmMDx ® for Prostate Cancer

Over 975,000 American men are diagnosed with a negative prostate biopsy each year; however approximately 25-35% of those men receive false-negative results. Under the current standard of care, prostate biopsy procedures consisting of 10-12 needle biopsy cores only sample approximately 1% of a man's prostate.  This approach leaves men at risk of undetected cancer, leading to a high rate of repeat biopsies, even on cancer-free men.  There is an unmet medical need for a clinically effective diagnostic test to address this dilemma.  ConfirmMDx for Prostate Cancer is able to detect an epigenetic field effect or "halo" associated with the cancerization process at the DNA level. This "halo" around a cancer lesion can be present despite cells having a normal appearance under the microscope. Thus ConfirmMDx for Prostate Cancer aids urologists in identifying truly negative men who may forego an unnecessary repeat biopsy procedure. Performance of the proprietary ConfirmMDx genes and technology has been published in 45 studies on over 5,000 patients tested. The ConfirmMDx test has qualified for Medicare reimbursement as of November 3, 2014 and is also available to more than 152 million insured lives via private health insurance plans.

About MDxHealth

MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation (epigenetic) technology and assist physicians with the diagnosis of cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information visit mdxhealth.com and follow us on Twitter at: twitter.com/mdxhealth .

For more information:

Dr Jan Groen, CEO Mike Sinclair (media)  
MDxHealth Halsin Partners  
US : +1 949 812 6979 UK: +44 20 7318 2955   
BE: +32 4 364 20 70 Cell: +44 7968 022075  
info@mdxhealth.com msinclair@halsin.com  

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.  This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws.

NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

To access the PDF version, click here http://hugin.info/137314/R/1921481/688673.pdf

HUG#1921481

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Illumina's Virtual Cell Win Raises Bigger AI Stakes

Updated Category News Views 54

A blind prediction contest is a useful place to separate glossy AI talk from actual biology. Illumina's BioInsight AI Lab took first place in Arc Institute's 2026 Virtual Cell Challenge, outperforming roughly 1,500 competitors on predictions of how cells would react when genes were knocked down. That is not a quarterly revenue number, and nobody should pretend otherwise....

Continue Reading
AI Shopping Answers Are Becoming Retail's New Shelf

Updated Category News Views 6

Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...

Continue Reading
Fromm Day Marks 50 Years of Learning and Connection

Updated Category News Views 65

A city proclamation can be fluffy civic confetti, but this one lands differently. San Francisco declared Nov. 14, 2026, Fromm Day as the Fromm Institute for Lifelong Learning marked its 50th anniversary, and the underlying story is sturdier than a ceremonial photo op. A program that began in 1976 expecting roughly 50 people at an open house drew about 150 students in its...

Continue Reading
PenFed’s Toys for Tots Drive Targets Holiday Gift Gaps

Updated Category News Views 116

A missing present under a tree is not a statistic anybody ought to glide past. PenFed Credit Union has opened its annual Toys for Tots collection across Washington-region branches, taking new, unwrapped toys through December 8 at 1:00 p.m. ET. The useful detail, and frankly the one worth remembering when people default to buying the easiest shiny thing on a shelf, is...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 130

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
DHC’s Ulta Rollout Gets a Useful Pricing Correction

Updated Category News Views 49

A face-wash price tag just became the most revealing part of DHC’s Ulta expansion. The company corrected an earlier announcement that had listed its new Deep Cleansing Face Wash at $31.50; the actual price is $19.00. That may sound like tiny housekeeping, and in the grand scheme it is, but consumer brands live or die on this kind of detail. A cleanser priced near $20...

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 75

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
Fresha Pushes Beauty Bookings Into AI Search Channels

Updated Category News Views 80

A haircut search is turning into a distribution fight, and Fresha has planted itself squarely in the middle of it. The company’s new Partner Network pushes its beauty and wellness marketplace beyond its own app and website into Google Search, Google Maps, Google’s AI experiences, ChatGPT, Claude, and eventually Alexa. That sounds like another glossy AI announcement...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 91

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading

Top 5 Most Recently Viewed Articles

Massimo Group Sees Growth Amid Challenges in Q3 2024

Updated Category News Views 362

Massimo Group Reports Solid Year-to-Date Revenue Growth Massimo Group (NASDAQ: MAMO) has shared encouraging financial results for the year so far, showcasing a remarkable 20.8% increase in revenue year-over-year (YoY), totaling $91.2 million. This positive trend is largely attributed to the company's innovative production, product enhancements, and effective sales...

Continue Reading
Earnings Preview: What to Expect from Dayforce's Q2 Results

Updated Category News Views 246

Anticipation for Dayforce's Upcoming Earnings Dayforce (NYSE: DAY) is gearing up for its quarterly earnings announcement, which is scheduled for a Wednesday. Investors are eagerly awaiting insights into the company's performance, particularly focusing on earnings surpassing estimates and positive guidance for future quarters. Analyst Expectations Industry analysts predict...

Continue Reading
AutoRABIT CodeScan Enhances Security for AI-Driven Code

Updated Category News Views 71

The Essential Role of AutoRABIT CodeScan in AI Security As artificial intelligence shapes the landscape of software development, it brings both exciting innovations and significant security challenges. AutoRABIT CodeScan stands out as a crucial tool designed to address these vulnerabilities, helping developers work safely with AI-generated code. Exploring the Risks of AI...

Continue Reading
Mythos AI Breaks New Ground in Autonomous Shipping Navigation

Updated Category News Views 240

Mythos AI Achieves Milestone in Autonomous Navigation In a groundbreaking achievement, Mythos AI has successfully surpassed 11,000 miles of fully autonomous navigation, marking a significant advancement in shipping technology. The company's AI-driven navigation system not only exceeds military-grade capabilities in safety and operational efficiency but also sets a new...

Continue Reading
Explore the Rich Tapestry of Michigan's Harvest Season

Updated Category News Views 218

Experience Michigan's Harvest Season As autumn settles in, Michigan transforms into a breathtaking landscape filled with vibrant colors and rich traditions. This time of year, the state's famous agriculture thrives, creating an atmosphere that beckons travelers to experience the harvest season to the fullest. From golden fields of corn to sprawling orchards full of ripe...

Continue Reading